Geron Corp (GERN) 4.14 $GERN Geron (GERN) Is St
Post# of 64200
Posted On: 03/16/2015 1:50:09 PM
Geron Corp (GERN) 4.14 $GERN
Geron (GERN) Is Strong On High Volume Today
at The Street - Fri Mar 13, 9:03AM CDT
Trade-Ideas LLC identified Geron (GERN) as a strong on high relative volume candidate
GERN: 4.14 (-0.20)
Geron Corporation (GERN) Jumps: Stock Rises 5.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 13, 8:32AM CDT
Geron Corporation (GERN) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
GERN: 4.14 (-0.20), ACOR: 34.58 (+0.23)
Most active Nasdaq-traded stocks
AP - Thu Mar 12, 12:56PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
MU: 28.25 (-0.47), FITB: 19.24 (+0.16), ACAD: 34.35 (-0.10), AMD: 2.78 (+0.03), FB: 77.59 (-0.46), ZGNX: 1.31 (+0.01), GERN: 4.14 (-0.20), MSFT: 41.35 (-0.03), INTC: 30.80 (-0.13), AAPL: 124.13 (+0.54), CSCO: 28.22 (+0.28)
Geron getting some Acadia-stoked love
Seeking Alpha - at Seeking Alpha - Tue Mar 10, 2:51PM CDT
JNJ: 100.62 (+1.41), ACAD: 34.35 (-0.10), PCYC: 256.00 (+1.02), GERN: 4.14 (-0.20), ABBV: 58.86 (+0.86)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Mar 10, 11:45AM CDT
HTBX: 7.70 (+0.35), CTRV: 4.16 (+0.11), AKRX: 42.88 (+1.60), BRSS: 15.20 (+0.39), CASI: 1.50 (+0.01), JOB: 1.07 (-0.01), LL: 29.09 (-1.46), MIND: 5.35 (-0.08), BBNK: 26.47 (+0.26), WPRT: 4.02 (-0.24), URBN: 44.61 (-0.22), OCC: 4.58 (+0.03), SYN: 2.70 (-0.19), IDT: 17.26 (-0.62), GERN: 4.14 (-0.20), TITN: 12.92 (+0.15), IMPV: 42.81 (+0.78), NNBR: 21.01 (+0.06), REPH: 6.78 (+0.83), VPCO: 1.12 (+0.01)
Geron Up 11.4%, Shares Break Through Resistance (GERN)
Comtex SmarTrend(R) - Tue Mar 10, 10:15AM CDT
Geron (NASDAQ:GERN) is one of today's best performing low-priced stocks, up 11.4% to $4.08 on 4.2x average daily volume. Geron has traded 11.6 million shares thus far today, vs. average volume of 2.7 million shares per day. The stock has outperformed the Dow (11.4% to the Dow's -1.1%) and outperformed the S&P 500 (11.4% to the S&P's -1.0%) during today's trading.
GERN: 4.14 (-0.20)
Trade-Ideas: Geron (GERN) Is Today's "Dead Cat Bounce" Stock
at The Street - Mon Mar 09, 9:19AM CDT
Trade-Ideas LLC identified Geron (GERN) as a "dead cat bounce" (down big yesterday but up big today) candidate
GERN: 4.14 (-0.20)
Geron (GERN) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 09, 9:08AM CDT
Geron (GERN) Shares March Higher, Can It Continue?
GERN: 4.14 (-0.20)
Seeking Alpha's Biotech Weekly: AbbVie - Pharmacyclitics, Orexigen Confusion, And More
SA Editor Mike Taylor - at Seeking Alpha - Fri Mar 06, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
PCYC: 256.00 (+1.02), MDT: 77.46 (+0.99), ARWR: 7.37 (-0.16), SPHS: 0.57 (+0.01), BSX: 17.30 (+0.69), MDVN: 130.58 (+1.91), JNJ: 100.62 (+1.41), AAC: 28.50 (+0.76), ABBV: 58.86 (+0.86), SNY: 48.66 (+1.59), SMMT: 10.85 (+0.15), ARNA: 4.71 (-0.10), XLRN: 41.10 (-0.10), MNK: 126.25 (+2.13), AQXP: 11.67 (-0.41), PFE: 34.42 (+0.42), AMGN: 161.90 (+7.64), GSK: 46.93 (+0.56), BMY: 67.83 (+0.96), MNKD: 5.45 (-0.06), CELG: 120.20 (+2.47), OREX: 6.94 (-0.10), PODD: 35.53 (+0.45), GERN: 4.14 (-0.20), TEVA: 60.58 (+0.58), TCON: 14.79 (+1.04), NVS: 97.93 (+0.89)
Geron gets boost from AbbVie-Pharmacyclics deal
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 11:15AM CST
JNJ: 100.62 (+1.41), PCYC: 256.00 (+1.02), GERN: 4.14 (-0.20), ABBV: 58.86 (+0.86)
Geron (GERN) Flagged As Strong On High Volume
at The Street - Thu Mar 05, 9:03AM CST
Trade-Ideas LLC identified Geron (GERN) as a strong on high relative volume candidate
GERN: 4.14 (-0.20)
Key Takeaways From Geron's Earnings Release
Kanak Kanti De - at Seeking Alpha - Wed Mar 04, 2:49PM CST
GERN: 4.14 (-0.20)
Geron's Q4 Loss Narrows Y/Y, Announces Restructuring Plan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 9:50AM CST
Geron Corporation (GERN) reported a fourth-quarter 2014 loss of 6 cents per share, a penny narrower than the year-ago loss of 7 cents. The Zacks Consensus Estimate was earnings of 17 cents.
JNJ: 100.62 (+1.41), GERN: 4.14 (-0.20), MRK: 57.06 (+0.86), BMY: 67.83 (+0.96)
Geron net loss improves in Q4 and FY14
Seeking Alpha - at Seeking Alpha - Wed Mar 04, 8:13AM CST
GERN: 4.14 (-0.20)
Geron Is Proof That Biotech Bargains Still Exist
Stock Doctor - Seeking Alpha - Wed Mar 04, 8:13AM CST
With the biotechnology sector hitting new highs every day and small biotech stocks sporting billion dollar valuations with minimal drug data, there are not many bargains left on the market. A little over a month ago, I recommended the small cap...
JNJ: 100.62 (+1.41), GERN: 4.14 (-0.20)
Geron's (GERN) CEO Dr. John Scarlett on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Mar 03, 7:03PM CST
GERN: 4.14 (-0.20)
Geron (GERN) Is Strong On High Volume Today
at The Street - Fri Mar 13, 9:03AM CDT
Trade-Ideas LLC identified Geron (GERN) as a strong on high relative volume candidate
GERN: 4.14 (-0.20)
Geron Corporation (GERN) Jumps: Stock Rises 5.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 13, 8:32AM CDT
Geron Corporation (GERN) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
GERN: 4.14 (-0.20), ACOR: 34.58 (+0.23)
Most active Nasdaq-traded stocks
AP - Thu Mar 12, 12:56PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
MU: 28.25 (-0.47), FITB: 19.24 (+0.16), ACAD: 34.35 (-0.10), AMD: 2.78 (+0.03), FB: 77.59 (-0.46), ZGNX: 1.31 (+0.01), GERN: 4.14 (-0.20), MSFT: 41.35 (-0.03), INTC: 30.80 (-0.13), AAPL: 124.13 (+0.54), CSCO: 28.22 (+0.28)
Geron getting some Acadia-stoked love
Seeking Alpha - at Seeking Alpha - Tue Mar 10, 2:51PM CDT
JNJ: 100.62 (+1.41), ACAD: 34.35 (-0.10), PCYC: 256.00 (+1.02), GERN: 4.14 (-0.20), ABBV: 58.86 (+0.86)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Mar 10, 11:45AM CDT
HTBX: 7.70 (+0.35), CTRV: 4.16 (+0.11), AKRX: 42.88 (+1.60), BRSS: 15.20 (+0.39), CASI: 1.50 (+0.01), JOB: 1.07 (-0.01), LL: 29.09 (-1.46), MIND: 5.35 (-0.08), BBNK: 26.47 (+0.26), WPRT: 4.02 (-0.24), URBN: 44.61 (-0.22), OCC: 4.58 (+0.03), SYN: 2.70 (-0.19), IDT: 17.26 (-0.62), GERN: 4.14 (-0.20), TITN: 12.92 (+0.15), IMPV: 42.81 (+0.78), NNBR: 21.01 (+0.06), REPH: 6.78 (+0.83), VPCO: 1.12 (+0.01)
Geron Up 11.4%, Shares Break Through Resistance (GERN)
Comtex SmarTrend(R) - Tue Mar 10, 10:15AM CDT
Geron (NASDAQ:GERN) is one of today's best performing low-priced stocks, up 11.4% to $4.08 on 4.2x average daily volume. Geron has traded 11.6 million shares thus far today, vs. average volume of 2.7 million shares per day. The stock has outperformed the Dow (11.4% to the Dow's -1.1%) and outperformed the S&P 500 (11.4% to the S&P's -1.0%) during today's trading.
GERN: 4.14 (-0.20)
Trade-Ideas: Geron (GERN) Is Today's "Dead Cat Bounce" Stock
at The Street - Mon Mar 09, 9:19AM CDT
Trade-Ideas LLC identified Geron (GERN) as a "dead cat bounce" (down big yesterday but up big today) candidate
GERN: 4.14 (-0.20)
Geron (GERN) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 09, 9:08AM CDT
Geron (GERN) Shares March Higher, Can It Continue?
GERN: 4.14 (-0.20)
Seeking Alpha's Biotech Weekly: AbbVie - Pharmacyclitics, Orexigen Confusion, And More
SA Editor Mike Taylor - at Seeking Alpha - Fri Mar 06, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
PCYC: 256.00 (+1.02), MDT: 77.46 (+0.99), ARWR: 7.37 (-0.16), SPHS: 0.57 (+0.01), BSX: 17.30 (+0.69), MDVN: 130.58 (+1.91), JNJ: 100.62 (+1.41), AAC: 28.50 (+0.76), ABBV: 58.86 (+0.86), SNY: 48.66 (+1.59), SMMT: 10.85 (+0.15), ARNA: 4.71 (-0.10), XLRN: 41.10 (-0.10), MNK: 126.25 (+2.13), AQXP: 11.67 (-0.41), PFE: 34.42 (+0.42), AMGN: 161.90 (+7.64), GSK: 46.93 (+0.56), BMY: 67.83 (+0.96), MNKD: 5.45 (-0.06), CELG: 120.20 (+2.47), OREX: 6.94 (-0.10), PODD: 35.53 (+0.45), GERN: 4.14 (-0.20), TEVA: 60.58 (+0.58), TCON: 14.79 (+1.04), NVS: 97.93 (+0.89)
Geron gets boost from AbbVie-Pharmacyclics deal
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 11:15AM CST
JNJ: 100.62 (+1.41), PCYC: 256.00 (+1.02), GERN: 4.14 (-0.20), ABBV: 58.86 (+0.86)
Geron (GERN) Flagged As Strong On High Volume
at The Street - Thu Mar 05, 9:03AM CST
Trade-Ideas LLC identified Geron (GERN) as a strong on high relative volume candidate
GERN: 4.14 (-0.20)
Key Takeaways From Geron's Earnings Release
Kanak Kanti De - at Seeking Alpha - Wed Mar 04, 2:49PM CST
GERN: 4.14 (-0.20)
Geron's Q4 Loss Narrows Y/Y, Announces Restructuring Plan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 9:50AM CST
Geron Corporation (GERN) reported a fourth-quarter 2014 loss of 6 cents per share, a penny narrower than the year-ago loss of 7 cents. The Zacks Consensus Estimate was earnings of 17 cents.
JNJ: 100.62 (+1.41), GERN: 4.14 (-0.20), MRK: 57.06 (+0.86), BMY: 67.83 (+0.96)
Geron net loss improves in Q4 and FY14
Seeking Alpha - at Seeking Alpha - Wed Mar 04, 8:13AM CST
GERN: 4.14 (-0.20)
Geron Is Proof That Biotech Bargains Still Exist
Stock Doctor - Seeking Alpha - Wed Mar 04, 8:13AM CST
With the biotechnology sector hitting new highs every day and small biotech stocks sporting billion dollar valuations with minimal drug data, there are not many bargains left on the market. A little over a month ago, I recommended the small cap...
JNJ: 100.62 (+1.41), GERN: 4.14 (-0.20)
Geron's (GERN) CEO Dr. John Scarlett on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Mar 03, 7:03PM CST
GERN: 4.14 (-0.20)
(0)
(0)